4th PAT and Real Time Quality Summit

As demand surges for GLP-1s, small molecules, and complex biologics, the industry faces increasing pressure to innovate and optimize manufacturing processes to meet the needs of Pharma 4.0. The 4th PAT and Real Time Quality Summit offers a unique opportunity to explore how Process Analytical Technology is transforming drug development and manufacturing, ensuring product consistency and reducing waste.

Across three days, 18+ industry leaders will share case studies, discuss the latest analytical tools, and demonstrate how digital technologies can be applied throughout the biologics and drug product lifecycle to save time and money. Attendees will dive into key topics, including regulatory updates, real-time release testing, and tech transfer challenges, while exploring the application of PAT for various drug modalities, including CGT, vaccines, peptides, and small molecules.

With experts from top pharma companies such as AstraZeneca, GlaxoSmithKline, and Pfizer, this summit provides an unmatched platform to discuss strategies for improving processes and accelerating the adoption of scalable, cost-effective PAT solutions.

Don't miss the chance to connect with other PAT practitioners and gain the insights needed to navigate the future of pharma manufacturing.

 

Prices:
Pharma, Biotech and CDMO Pricing - Full Access Pass (Conference + 2 Workshops): USD 4197.00,
Pharma, Biotech and CDMO Pricing - 3 Day Pass (Conference + 1 Workshop): USD 3598.00,
Pharma, Biotech and CDMO Pricing - 2 Day Pass (Conference Only): USD 2999.00,
Academic Pricing - Full Access Pass (Conference + 2 Workshops): USD 3597.00,
Academic Pricing - 3 Day Pass (Conference + 1 Workshop): USD 3098.00,
Academic Pricing - 2 Day Pass (Conference Only): USD 2599.00,
Solution Provider Pricing - Full Access Pass (Conference + 2 Workshops): USD 5097.00,
Solution Provider Pricing - 3 Day Pass (Conference + 1 Workshop): USD 4398.00,
Solution Provider Pricing - 2 Day Pass (Conference Only): USD 3699.00

Speakers: Sankaran Anantharaman, Principal Research Scientist II, Analytical Sciences, Product Development Science and Technology, AbbVie, Preeya Boppana, Director, Manufacturing Science and Technology, Process Analytics and Laboratories, AstraZeneca, Veera Padmanabhan, Executive Director and Head of Manufacturing Sciences and Technology, AstraZeneca, Edita Botonjic-Sehic, Head of Process Analytical Technology, Recipharm, Claudia Corredor, Senior Principal Scientist, Bristol Myers Squibb, Lenora Dieyi, Investigator, Modeling and Simulation, GSK, Mario Hellings, Scientific Director, Analytical Development, Johnson and Johnson, Yuxin He, Senior Engineer, Moderna, Renee Hart, President and Chief Business Officer, LumaCyte, Carrie Mason, Head, Process Analytical Technology Center of Excellence, Research and Development, Lonza Integrated Biologics, Lonza, Ryan MacDougall, Lead Scientist, Process Science and Technology Biologics Research and Development, Lonza, Christine Massie, Process Analytical Technology Scientist, Sanofi, Farshid Mohammadparast, Principal Investigator, Process Analytical Technology and Chemometrics, US Pharmacopeia, Darren Whitaker, Associate Director of Automation and Control in Process Chemistry Development, Takeda, Dunie Navarro, Senior Scientist, Upstream Process Development, Pfizer, Fernando Nunes de Barros, Modeling and Process Analytical Technology Manager, Hovione, Ramila Peiris, Global Head of Process Data Management, ML AND AI Platform, MSAT, Sanofi, Shashi Prajapati, Director, Analytical Development, Vertex Cell and Genetic Therapies, Head of Analytical Testing, Operations, Automation and Technologies, Vertex Pharmaceuticals

Others Details

Brochure: https://go.evvnt.com/3112785-3?pid=6581 Category: Conferences | Engineering & Technology | Manufacturing